Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Detection of Myocardial Iron Overload with Magnetic Resonance By Native T1 and T2* Mapping Using a Segmental Approach

Alessia Pepe, MD, Laura Pistoia, Nicola Martini, Daniele De Marchi, Andrea Barison, Aurelio Maggio, MD, Piera Giovangrossi, Simona Bulgarelli, F. Mehtap Pasin, Roberto Sarli, Antonella Massa, Gaetano Roccamo, Mauro Caini, Vincenzo Positano, Antonella Meloni, PhD

Blood (2018) 132 (Supplement 1): 2346.

https://doi.org/10.1182/blood-2018-99-112559

Published: 2018

Journal Articles

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Angela Vitrano, PhD, Massimiliano Sacco, DR, Rosamaria Rosso, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Esther Natalie Oliva, MD, Calogera Gerardi, MD, Gaetano Roccamo, MD, Vincenzo Spadola, MD, Aldo Filosa, MD, Lorenzo Tesé, MD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Laura Mistretta, DR, Filippo Cassarà, DR, Rosario Di Maggio, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 936.

https://doi.org/10.1182/blood.V130.Suppl_1.936.936

Published: 2017

Journal Articles

The Prognostic Role of Hypertrabeculation By Cardiac Magnetic Resonance in Thalassemia Intermedia Patients

Alessia Pepe, Francesca Macaione, Pietro Giuliano, Laura Pistoia, Angelica Barone, Roberto Sarli, Gaetano Roccamo, Aurelio Maggio, MD, Vincenzo Positano, Stefania Renne, Pasquale Assennato, Antonella Meloni

Blood (2016) 128 (22): 3625.

https://doi.org/10.1182/blood.V128.22.3625.3625

Published: 2016

Journal Articles

Prevalence of Extramedullary Hematopoiesis, Vertebral, Hepatic and Splenic Hemangioma and Renal Cyst Among Thalassaemic Patients: A Retrospective Study from the Myocardial Iron in Thalassemia (MIOT) Network

Alessia Pepe, Antonella Meloni, Alessandra Briatico Vangosa, Fabrizia Terrazzino, Maria Giovanna Neri, Domenico Maddaloni, Gaetano Roccamo, Sabrina Armari, Aurelio Maggio, MD, Cristina Salvatori, Vincenzo Positano, Paolo Ricchi

Blood (2015) 126 (23): 2154.

https://doi.org/10.1182/blood.V126.23.2154.2154

Published: 2015

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

Direct Cost Analysis About The Three Chelators For The Treatment Of Thalassemia Patients With Chronic Iron Overload: An Italian Perspective From The MIOT Network

Alessia Pepe, MD, PhD, Antonella Meloni, PhD, Giuseppe Rossi, MSc, Antonella Carollo, MD, Vincenzo Santamaria, MD, Augusto Scaccetti, MD, Gaetano Roccamo, MD, Aurelio Maggio, MD, Massimo Lombardi, MD

Blood (2013) 122 (21): 5605.

https://doi.org/10.1182/blood.V122.21.5605.5605

Published: 2013

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Right Ventricular Volumes and Function Normalized to Body Surface Area, Age and Sex in a Large Cohort of Well-Treated Thalassemia Major without Myocardial Iron Overload

Antonella Meloni, PhD, Giovanni Aquaro, Lamia Ait-Ali, Saveria Campisi, Domenico Giuseppe D'Ascola, Antonella Quarta, M.D., Pier Paolo Bitti, Gaetano Roccamo, M.D., Maria Grazia Bisconte, Basilia Piraino, Maria Eliana Lai, Angelo Peluso, Stefania Renne, Lucia De Franceschi, MD, Vincenzo Positano, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 5293.

https://doi.org/10.1182/blood.V118.21.5293.5293

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Single ROI Versus Multislice T2* MRI Approach for the Quantification of Hepatic Iron Overload

Antonella Meloni, PhD, Antongiulio Luciani, PhD, Vincenzo Positano, PhD, Daniele De Marchi, PhD, Gianluca Valeri, PhD, Gennaro Restaino, PhD, Gaetano Roccamo, PhD, Sabrina Armari, PhD, Maria Chiara Dell'Amico, PhD, Brunella Favilli, Alma Lippi, MD, Massimo Lombardi, PhD, Alessia Pepe, PhD

Blood (2010) 116 (21): 4263.

https://doi.org/10.1182/blood.V116.21.4263.4263

Published: 2010

Journal Articles

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Blood (2008) 112 (11): 3885.

https://doi.org/10.1182/blood.V112.11.3885.3885

Published: 2008

Journal Articles

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Blood (2007) 110 (11): 575.

https://doi.org/10.1182/blood.V110.11.575.575

Published: 2007

NARROW

Detection of Myocardial Iron Overload with Magnetic Resonance By Native T1 and T2* Mapping Using a Segmental Approach

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

The Prognostic Role of Hypertrabeculation By Cardiac Magnetic Resonance in Thalassemia Intermedia Patients

Prevalence of Extramedullary Hematopoiesis, Vertebral, Hepatic and Splenic Hemangioma and Renal Cyst Among Thalassaemic Patients: A Retrospective Study from the Myocardial Iron in Thalassemia (MIOT) Network

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Direct Cost Analysis About The Three Chelators For The Treatment Of Thalassemia Patients With Chronic Iron Overload: An Italian Perspective From The MIOT Network

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Right Ventricular Volumes and Function Normalized to Body Surface Area, Age and Sex in a Large Cohort of Well-Treated Thalassemia Major without Myocardial Iron Overload

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Single ROI Versus Multislice T2* MRI Approach for the Quantification of Hepatic Iron Overload

Decrease of Mortality during Deferiprone Treatments: Results from A Large Randomised Cohort of Thalassemia Major Patients Under the Auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only